References
1. Allarakia S, Khayat HA, Karami MM, et
al. Characteristics and management
of mirror syndrome: a systematic review (1956-2016). J Perinat
Med . 2017;45(9):1013-1021.
2. Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the
identification and management of a chronic condition in oncologic
treatment. Ca-Cancer J Clin . 2009;59(1):8-24.
3. Czernik C, Proquitté H, Metze B, Bührer C. Hydrops fetalis–has
there been a change in diagnostic spectrum and mortality? J
Matern-Fetal Neonat Med . 2011;24(2):258-263.
4. Porat S, Fitzgerald B, Wright E, Keating S, Kingdom JC. Placental
hyperinflation and the risk of adverse perinatal outcome.Ultrasound Obstet Gynecol . 2013;42(3):315-321.
5. Braun T, Brauer M, Fuchs I, et al. Mirror syndrome: a systematic
review of fetal associated conditions, maternal presentation and
perinatal outcome. Fetal Diagn Ther . 2010;27(4):191-203.
6. Takci S, Gharibzadeh M, Yurdakok M, et al. Etiology and outcome of
hydrops fetalis: report of 62 cases. Pediatr Neonatol .
2014;55(2):108-113.
7. McEwan A. Fetal anaemia. Obstet Gynaecol Reprod Med .
2019;29(8):233-239.
8. Gaetani M, Damiani gr, Pellegrino A, et al. Diagnosis and management
of a rare case of fetal mediastinal teratoma without non-immunological
hydrops. J Obstet Gynaecol . 2015;36:1-3.
9. Moise KJ, Jr. Management of rhesus alloimmunization in pregnancy.Obstet Gynecol . 2008;112(1):164-176.
10. Sohan K, Carroll SG, De La Fuente S, Soothill P, Kyle P. Analysis of
outcome in hydrops fetalis in relation to gestational age at diagnosis,
cause and treatment. Acta Obstet Gynecol Scand .
2001;80(8):726-730.
11. Hobson SR, Wallace EM, Chan YF, Edwards AG, Teoh MWT, Khaw AP.
Mirroring preeclampsia: the molecular basis of Ballantyne syndrome.J Matern-Fetal Neonat Med . 2020;33(5):768-773.
12. ACOG practice bulletin no. 192: management of alloimmunization
during pregnancy. Obstet Gynecol . 2018;131(3):e82-e90.
13. Krishnan V, Shenoy V, Sunny S, et al. Defining critical antibody
titre in column agglutination method to guide fetal surveillance.Transfus Apher Sci . 2020;59(3):102732.
14. Martinez-Portilla RJ, Lopez-Felix J, Hawkins-Villareal A, et al.
Performance of fetal middle cerebral artery peak systolic velocity for
prediction of anemia in untransfused and transfused fetuses: systematic
review and meta-analysis. https://doi.org/10.1002/uog.20273.Ultrasound Obstet Gynecol . 2019;54(6):722-731.
15. Deleers M, Guizani M, Jani J, Hulot M, El Kenz H. A case of severe
foetal anaemia due to anti-Kell that could not be detected by the weekly
assessment of middle cerebral artery peak systolic velocity.Transfus Apher Sci . 2018;57(1):111-113.
16. Arslan E, Demir SC, Ozsurmeli M, Akcabay C. Perinatal outcomes and
survival predictors of severe red-cell alloimmunization treated by
intrauterine transfusion. J Obstet Gynaecol .
2021;47(8):2632-2640.
Smoleniec J, Anderson N, Poole G. Hydrops fetalis caused by a blood
group antibody usually undetected in routine screening. Archives of
disease in childhood Fetal and neonatal edition. 1994;71(3):F216-217.
18. Koshy R, Patel B, Harrison JS. Anti-Kpa-induced severe delayed
hemolytic transfusion reaction. Immunohematology. 2009;25(2):44-47
19. Le Vaillant C, Jacopin-Bruneau L, Nowak C, Riteau AS. Two cases of
unusual allo-immunization caused by atypical antibodies. Presse medicale
(Paris, France : 1983).2015;44(10):1078-1082.Allo-immunisation
materno-fœtale par anticorps atypiques à propos de deux cas cliniques.
20. Brumbaugh JE, Morgan S, Beck JC, et al. Blueberry muffin rash,
hyperbilirubinemia, and hypoglycemia: a case of hemolytic disease of the
fetus and newborn due to anti-Kp(a). Journal of perinatology : official
journal of the California Perinatal Association. 2011;31(5):373-376.
21. Geczy A, Ennis J, Golian PR. A further example of anti-kpa.
Transfusion. 1965;5:89-91.
22. Costamagna L, Barbarini M, Viarengo GL, Pagani A, Isernia D,
Salvaneschi L. A case of hemolytic disease of the newborn due to
anti-Kpa. Immunohematology. 1997;13(2):61-62.
23. Tuson M, Hue-Roye K, Koval K, et al. Possible suppression of fetal
erythropoiesis by the Kell blood group antibody anti-Kp(a).
Immunohematology. 2011;27(2):58-60.